Wash. Admin. Code § 246-945-056

Current through Register Vol. 24-23, December 1, 2024

Section 246-945-056 - Schedule V

The commission finds that the following substances have low potential for abuse relative to substances in Schedule IV under RCW 69.50.210 and WAC 246-945-055 and have currently accepted medical use in treatment in the United States and that the substances have limited physical dependence or psychological dependence liability relative to the substance in Schedule IV. In addition to the substances listed in RCW 69.50.212, the commission places each of the following drugs and substances by whatever official name, common or usual name, chemical name, or brand name in Schedule V.

Depressants. Unless specifically exempted or excluded or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts:

(1) Brivaracetam ((2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl] bu-tanamide); also referred to as BRV; UCB-34714; Briviact;

(2) Ezogabine [N-[2-amino-4-(4-fluorobenzylamino)-phenyl]-carba-mic acid ethyl ester].

Wash. Admin. Code § 246-945-056

Adopted by WSR 20-12-072, Filed 6/1/2020, effective 7/1/2020, and 3/1/2021

Amended by WSR 22-10-044, Filed 4/28/2022, effective 5/29/2022

Reviser's note: The brackets and enclosed material in the text of the above section occurred in the copy filed by the agency.